Updated Oct 27, 2026 · 09:24 UTC
JNJJohnson & Johnson
Health Care · United States · XNYS · pharmaceutical preparations
$266.46+0.94%last session · market early-hours
Market cap
$641.45b
real-world
Tokenized
$631k
<0.001% of the asset
Avg token price
$268.80
+0.88% vs real
Spot volume, 24h
$112k
4 venues
Derivatives, 24h
$1.9m
0.1% of real volume
Perp open interest
$1.7m
9 venues
In DeFi
—
JNJ · Price
Token Real
EarningsNasdaq’s earnings calendar
Last earnings, Oct 13
$2.59 EPS
+2.4% vs $2.53 forecast · Sep 2026 quarter
Real marketJohnson & Johnson
Last close
$263.81
Oct 23
Traded on Oct 23
$1.40b
Price now
$266.46
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $112k · 4 venues
Blynex1 pair$90k
OKX1 pair$21k
Kraken1 pair$424Derivatives · $1.9m · 9 venues · $1.7m open interest
BingX1 pair · OI $985k · funding +0.0050%$1.6m
Bybit1 pair · OI $170k · funding +0.0000%$92kOKX1 pair · OI $259k · funding +0.0000%$77kIn DeFiPools and lending markets that hold these tokens
None found
Onchain versions4 tokens from 3 issuers
JNJXBacked Assets$266.54$588k
JNJonOndo Assets$269.20$32k
WJNJXBacked Assets$271.65$11k
JNJ.DDinari Assetstied here——HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain
Solana194 holders$351k
BNB Chain103 holders$4k
Ethereum69 holders$23k
X Layer20 holders$12k
TON8 holders$24k
Ink6 holders$12k
Arbitrum— holders$0Business 12 months to Sep 2026 · SEC EDGAR
Results
Revenue
$99.33b
+8% YoY
Net income
$16.09b
16% margin · −36% YoY
Gross margin
68%
−0.5 pts YoY
EPS, diluted
$6.57
−36% YoY
Diluted shares
2.45b
+1% YoY
Cash and balance sheet
Free cash flow
$20.59b
21% of revenue · 3.2% yield
Net debt
$27.42b
$17.23b cash and securities, $44.65b debt
Quarterly
RevenueNet income
Valuation today’s market cap $641.45b · enterprise value $668.87b
P/E
39.9×
EV / sales
6.7×